Comparison of topical 0.3% ofloxacin cefazolin in the fortified tobramycin- Cefazolin therapy of bacterial keratitis

Citation
S. Khokhar et al., Comparison of topical 0.3% ofloxacin cefazolin in the fortified tobramycin- Cefazolin therapy of bacterial keratitis, INFECTION, 28(3), 2000, pp. 149-152
Citations number
19
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
INFECTION
ISSN journal
03008126 → ACNP
Volume
28
Issue
3
Year of publication
2000
Pages
149 - 152
Database
ISI
SICI code
0300-8126(200005/06)28:3<149:COT0OC>2.0.ZU;2-F
Abstract
Background: In this study we compared topical ofloxacin with a combination of fortified tobramycin sulphate and cefazolin sodium solutions in the trea tment of culture-proved bacterial keratitis. Methods: 30 eyes of culture-proved bacterial corneal ulcers of moderate sev erity were included in a prospective randomized, controlled, double-masked study for comparison. The cases were randomly allocated to treatment with 0 .3% ofloxacin solution (Group I) and combination of fortified antibiotics ( 1.5% tobramycin and 5% cefazolin solutions - Group II as control) along wit h supportive cycloplegic, vitamins and antiglaucoma therapy, Time for heali ng of ulcer and subjective symptoms were main outcome measures. Student's t -test was used to compare the results, Results: Staphylococcus aureus and coagulase-negative staphylococci were th e two most common organisms isolated. Resolution of the ulcer was achieved in 93% and 87% in the treated and the control group, respectively The mean duration of symptomatic relief was 7.8 +/- 1.54 days in the treated group a nd 8.33 +/- 1.44 days in the control group; for epithelial healing it was 1 5.0 +/- 3.86 days in the treated group and 15.46 +/- 3.86 days in the contr ol group. Post resolution the best corrected visual acuity of 20/200 or bet ter was achieved in all but one eye each in both groups. Conclusions: Both ofloxacin 0.3% and combined fortified tobramycin 1.5% and cefazolin 5% topical drops were comparable for treating cases of bacterial corneal ulcer of moderate severity. However, considering the easy availabi lity and cost effectiveness of ofloxacin, a monotherapy with ofloxacin may be preferred over the combined, fortified tobramycin and cefazolin therapy.